A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma

References

• EckelRHAlbertiKGGrundySMZimmetPZThe metabolic syndromeLancet2010375971018118320109902
   PubMed Web of Science ®Google Scholar
• AgopianVGKaldasFMHongJCLiver transplantation for nonalcoholic steatohepatitis: the new epidemicAnn Surg2012256462463322964732
   PubMed Web of Science ®Google Scholar
• Fierbinteanu-BraticeviciCNegreanuLTarantinoGIs fatty liver always benign and should not consequently be treated?J Physiol Pharmacol20136413923568965
   PubMed Web of Science ®Google Scholar
• WelzelTMGraubardBIZeuzemSEl-SeragHBDavilaJAMcGlynnKAMetabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare databaseHepatology201154246347121538440
   PubMed Web of Science ®Google Scholar
• StarleyBQCalcagnoCJHarrisonSANonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connectionHepatology20105151820183220432259
   PubMed Web of Science ®Google Scholar
• AschaMSHanounehIALopezRTamimiTAFeldsteinAFZeinNNThe incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitisHepatology20105161972197820209604
   PubMed Web of Science ®Google Scholar
• TuratiFTalaminiRPelucchiCMetabolic syndrome and hepatocellular carcinoma riskBr J Cancer2013108122222823169288
   PubMed Web of Science ®Google Scholar
• CauchyFZalinskiSDokmakSSurgical treatment of hepatocellular carcinoma associated with the metabolic syndromeBr J Surg2013100111312123147992
   PubMed Web of Science ®Google Scholar
• WakaiTShiraiYSakataJKoritaPVAjiokaYHatakeyamaKSurgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver diseaseJ Gastrointest Surg20111581450145821512848
   PubMed Web of Science ®Google Scholar
• NealCPMannCDPointenEInfluence of hepatic parenchymal histology on outcome following right hepatic trisectionectomyJ Gastrointest Surg201216112064207322923210
   PubMed Web of Science ®Google Scholar
• ReddySKMarshJWVarleyPRUnderlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: A case-control studyHepatology20125662221223022767263
   PubMed Web of Science ®Google Scholar
• BhayaniNHHyderOFrederickWEffect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysisSurgery2012152221822622828143
   PubMed Web of Science ®Google Scholar
• Zarzavadjian Le BianACostiRConstantinidesVSmadjaCMetabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative riskJ Gastrointest Surg201216122247225523054903
   PubMed Web of Science ®Google Scholar
• El-SeragHBTranTEverhartJEDiabetes increases the risk of chronic liver disease and hepatocellular carcinomaGastroenterology2004126246046814762783
   PubMed Web of Science ®Google Scholar
• FiataroneJRCoverdaleSABateyRGFarrellGCNon-alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesisJ Gastroenterol Hepato199166585590
   Web of Science ®Google Scholar
• RatziuVGiralPCharlotteFLiver fibrosis in overweight patientsGastroenterology200011861117112310833486
   PubMed Web of Science ®Google Scholar
• GholamPMFlancbaumLMachanJTCharneyDAKotlerDPNonalcoholic fatty liver disease in severely obese subjectsAm J Gastroenterol2007102239940817311652
   PubMed Web of Science ®Google Scholar
• HuoTILuiWYHuangYHDiabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal studyAm J Gastroenterol200398102293229814572582
   PubMed Web of Science ®Google Scholar
• SlankamenacKBreitensteinSHeldUBeck-SchimmerBPuhanMAClavienPADevelopment and validation of a prediction score for postoperative acute renal failure following liver resectionAnn Surg2009250572072819809295
   PubMed Web of Science ®Google Scholar
• PathakSTangJMTerlizzoMPostonGJMalikHZHepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastasesEur J Surg Oncol2010361525719879103
   PubMed Web of Science ®Google Scholar
• MathurAKGhaferiAASellKSonnendayCJEnglesbeMJWellingTHInfluence of body mass index on complications and oncologic outcomes following hepatectomy for malignancyJ Gastrointest Surg201014584985720140536
   PubMed Web of Science ®Google Scholar
• ParadisVZalinskiSChelbiEHepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysisHepatology200949385185919115377
   PubMed Web of Science ®Google Scholar
• JanssenIKatzmarzykPTRossRBody mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelinesArch Intern Med2002162182074207912374515
   PubMedGoogle Scholar
• JanssenIKatzmarzykPTRossRWaist circumference and not body mass index explains obesity-related health riskAm J Clin Nutr200479337938414985210
   PubMed Web of Science ®Google Scholar
• BonoraETargherGAlbericheMHomeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivityDiabetes Care2000231576310857969
   PubMed Web of Science ®Google Scholar
• KleinerDEBruntEMVan NattaMNonalcoholic Steatohepatitis Clinical Research NetworkDesign and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology20054161313132115915461
   PubMed Web of Science ®Google Scholar
• BedossaPMoucariRChelbiEEvidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective studyHepatology200746238038717659580
   PubMed Web of Science ®Google Scholar
• MoucariRAsselahTCazals-HatemDInsulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosisGastroenterology2008134241642318164296
   PubMed Web of Science ®Google Scholar
• FernandezFGRitterJGoodwinJWLinehanDCHawkinsWGStrasbergSMEffect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastasesJ Am Coll Surg2005200684585315922194
   PubMed Web of Science ®Google Scholar
• VautheyJNPawlikTMRiberoDChemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastasesJ Clin Oncol200624132065207216648507
   PubMed Web of Science ®Google Scholar
• AnguloPNonalcoholic fatty liver diseaseN Engl J Med2002346161221123111961152
   PubMed Web of Science ®Google Scholar
• VuppalanchiRChalasaniNNonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and managementHepatology200949130631719065650
   PubMed Web of Science ®Google Scholar
• BruntEMKleinerDEWilsonLABeltPNeuschwander-TetriBANASH Clinical Research Network (CRN)Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meaningsHepatology201153381082021319198
   PubMed Web of Science ®Google Scholar
• BedossaPPoitouCVeyrieNHistopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patientsHepatology20125651751175922707395
   PubMed Web of Science ®Google Scholar
• BedossaPFLIP Pathology ConsortiumUtility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver diseaseHepatology201460256557524753132
   PubMed Web of Science ®Google Scholar
• MerrimanRBFerrellLDPattiMGCorrelation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver diseaseHepatology200644487488017006934
   PubMed Web of Science ®Google Scholar
• RatziuVCharlotteFHeurtierALIDO Study GroupSampling variability of liver biopsy in nonalcoholic fatty liver diseaseGastroenterology200512871898190615940625
   PubMed Web of Science ®Google Scholar
• McPhersonSStewartSFHendersonEBurtADDayCPSimple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseGut20105991265126920801772
   PubMed Web of Science ®Google Scholar
• RaptisDAFischerMAGrafRMRI: the new reference standard in quantifying hepatic steatosis?Gut201261111712721997548
   PubMed Web of Science ®Google Scholar
• BülowRMenselBMeffertPHernandoDEvertMKühnJPDiffusion-weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and ironEur Radiol20132351281128723138385
   PubMed Web of Science ®Google Scholar
• JinjuvadiaRPatelSLiangpunsakulSThe association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysisJ Clin Gastroenterol201448217217724402120
   PubMed Web of Science ®Google Scholar
• AraseYKobayashiMSuzukiFEffect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis CHepatology201357396497322991257
   PubMed Web of Science ®Google Scholar
• CalleEERodriguezCWalker-ThurmondKThunMJOverweight, obesity, and mortality from cancer in a prospectively studied cohort of US adultsN Engl J Med2003348171625163812711737
   PubMed Web of Science ®Google Scholar
• MichelottiGAMachadoMVDiehlAMNAFLD, NASH and liver cancerNat Rev Gastroenterol Hepatol2013101165666524080776
   PubMed Web of Science ®Google Scholar
• SaxenaNKFuPPNagalingamAAdiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinomaGastroenterology201013951762177320637208
   PubMed Web of Science ®Google Scholar
• ErtleJDechêneASowaJPNon-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosisInt J Cancer2011128102436244321128245
   PubMed Web of Science ®Google Scholar
• HashimotoEYatsujiSTobariMHepatocellular carcinoma in patients with nonalcoholic steatohepatitisJ Gastroenterol200944Suppl 19899519148800
   PubMed Web of Science ®Google Scholar
• YatsujiSHashimotoETobariMTaniaiMTokushigeKShiratoriKClinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis CJ Gastroenterol Hepatol200924224825419032450
   PubMed Web of Science ®Google Scholar
• SorrentinoPD’AngeloSFerboUMicheliPBraciglianoAVecchioneRLiver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitisJ Hepatol200950235135719070395
   PubMed Web of Science ®Google Scholar
• ValentiLFracanzaniALBugianesiEHFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver diseaseGastroenterology2010138390591219931264
   PubMed Web of Science ®Google Scholar
• AsselahTRubbia-BrandtLMarcellinPNegroFSteatosis in chronic hepatitis C: why does it really matter?Gut200655112313016344578
   PubMed Web of Science ®Google Scholar
• SerfatyLAndreaniTGiralPCarbonellNChazouillèresOPouponRHepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis CJ Hepatol200134342843411322205
   PubMed Web of Science ®Google Scholar
• SerfatyLPoujol-RobertACarbonellNChazouillèresOPouponREPouponREffect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis CAm J Gastroenterol20029771807181212135040
   PubMed Web of Science ®Google Scholar
• TakumaYNousoKMakinoYHepatic steatosis correlates with the postoperative recurrence of hepatitis C virus-associated hepatocellular carcinomaLiver Int200727562062617498246
   PubMed Web of Science ®Google Scholar
• ViganòLCapussottiLDe RosaGDe SaussureWOMenthaGRubbia-BrandtLLiver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survivalAnn Surg2013258573174224045448
   PubMed Web of Science ®Google Scholar
• BalzanSNagarajanGFargesOSafety of liver resections in obese and overweight patientsWorld J Surg201034122960296820711580
   PubMed Web of Science ®Google Scholar
• CucchettiACesconMErcolaniGDi GioiaPPeriEPinnaADSafety of hepatic resection in overweight and obese patients with cirrhosisBr J Surg20119881147115421509752
   PubMed Web of Science ®Google Scholar
• McCormackLPetrowskyHJochumWFurrerKClavienPAHepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control studyAnn Surg2007245692393017522518
   PubMed Web of Science ®Google Scholar
• VeteläinenRvan VlietAGoumaDJvan GulikTMSteatosis as a risk factor in liver surgeryAnn Surg20072451203017197961
   PubMed Web of Science ®Google Scholar
• de MeijerVEKalishBTPuderMIjzermansJNSystematic review and meta-analysis of steatosis as a risk factor in major hepatic resectionBr J Surg20109791331133920641066
   PubMed Web of Science ®Google Scholar
• VeteläinenRvan VlietAKvan GulikTMSevere steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomyAnn Surg20072451445017197964
   PubMed Web of Science ®Google Scholar
• VanwagnerLBBhaveMTeHSFeinglassJAlvarezLRinellaMEPatients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular eventsHepatology20125651741175022611040
   PubMed Web of Science ®Google Scholar
• WongVWWongGLYipGWCoronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver diseaseGut201160121721172721602530
   PubMed Web of Science ®Google Scholar
• VayáAHernández-MijaresABonetEAssociation between hemorheological alterations and metabolic syndromeClin Hemorheol Microcirc2011491–449350322214720
   PubMed Web of Science ®Google Scholar
• GyawaliPRichardsRSHughesDLTinleyPErythrocyte aggregation and metabolic syndromeClin Hemorheol Microcirc2014571738324192695
   PubMed Web of Science ®Google Scholar
• MelloulEDondéroFVilgrainVRaptisDAPaugam-BurtzCBelghitiJPulmonary embolism after elective liver resection: a prospective analysis of risk factorsJ Hepatol20125761268127522889956
   PubMed Web of Science ®Google Scholar
• CharltonMRBurnsJMPedersenRAWattKDHeimbachJKDierkhisingRAFrequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United StatesGastroenterology201114141249125321726509
   PubMed Web of Science ®Google Scholar
• BhagatVMindikogluALNudoCGSchiffERTzakisARegevAOutcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver diseaseLiver Transpl200915121814182019938128
   PubMed Web of Science ®Google Scholar
• MalikSMdeVeraMEFontesPShaikhOAhmadJOutcome after liver transplantation for NASH cirrhosisAm J Transplant2009978279319344467
   PubMed Web of Science ®Google Scholar
• HoulihanDDArmstrongMJDavidovYRenal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens?Liver Transpl2011171292129821761549
   PubMed Web of Science ®Google Scholar
• MadhwalSAtrejaAAlbeldawdiMLopezRPostACostaMAIs liver transplantation a risk factor for cardiovascular disease? A meta-analysis of observational studiesLiver Transpl201218101140114622821899
   PubMed Web of Science ®Google Scholar
• KennedyCReddenDGraySEquivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseasesHPB (Oxford)201214962563422882200
   PubMed Web of Science ®Google Scholar
• ReddySKSteelJLChenHWOutcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver diseaseHepatology20125561809181922183968
   PubMed Web of Science ®Google Scholar
• Hernandez-AlejandroRCroomeKPDrageMA comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinomaWorld J Gastroenterol201218314145414922919246
   PubMed Web of Science ®Google Scholar
• El AtracheMMAbouljoudMSDivineGRecurrence of nonalcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndromeClin Transplant2012265505512
   Web of Science ®Google Scholar
• PatilDTYerianLMEvolution of nonalcoholic fatty liver disease recurrence after liver transplantationLiver Transpl201218101147115322740341
   PubMed Web of Science ®Google Scholar
• MaedaHOkabayashiTNishimoriIYamashitaKSugimotoTHanazakiKHyperglycemia during hepatic resection: continuous monitoring of blood glucose concentrationAm J Surg2010199181319897172
   PubMed Web of Science ®Google Scholar
• OkabayashiTIchikawaKNamikawaTSugimotoTKobayashiMHanazakiKEffect of perioperative intensive insulin therapy for liver dysfunction after hepatic resectionWorld J Surg201135122773277821976008
   PubMed Web of Science ®Google Scholar
• MarsmanHAde GraafWHegerMHepatic regeneration and functional recovery following partial liver resection in an experimental model of hepatic steatosis treated with omega-3 fatty acidsBr J Surg2013100567468323456631
   PubMed Web of Science ®Google Scholar
• TorresDMHarrisonSADiagnosis and therapy of nonalcoholic steatohepatitisGastroenterology200813461682169818471547
   PubMed Web of Science ®Google Scholar
• BelfortRHarrisonSABrownKA placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitisN Engl J Med2006355222297230717135584
   PubMed Web of Science ®Google Scholar
• LavineJESchwimmerJBVan NattaMLNonalcoholic Steatohepatitis Clinical Research NetworkEffect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trialJAMA2011305161659166821521847
   PubMed Web of Science ®Google Scholar
• SanyalAJChalasaniNKowdleyKVPioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitisN Engl J Med2010362181675168520427778
   PubMed Web of Science ®Google Scholar
• HassanMMCurleySALiDAssociation of diabetes duration and diabetes treatment with the risk of hepatocellular carcinomaCancer201011681938194620166205
   PubMed Web of Science ®Google Scholar
• DonadonVBalbiMMasMDCasarinPZanetteGMetformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver diseaseLiver Int201030575075820331505
   PubMed Web of Science ®Google Scholar
• RochaGZDiasMMRopelleERMetformin amplifies chemotherapy-induced AMPK activation and antitumoral growthClin Cancer Res201117123993400521543517
   PubMed Web of Science ®Google Scholar
• PernicovaIKorbonitsMMetformin – mode of action and clinical implications for diabetes and cancerNat Rev Endocrinol201410314315624393785
   PubMed Web of Science ®Google Scholar
• BaselgaJCamponeMPiccartMEverolimus in postmenopausal hormone-receptor-positive advanced breast cancerN Engl J Med2012366652052922149876
   PubMed Web of Science ®Google Scholar
• HainsworthJDSpigelDRBurrisHA3rdWaterhouseDClarkBLWhorfRPhase II trial of bevacizumab and everolimus in patients with advanced renal cell carcinomaJ Clin Oncol201028132131213620368560
   PubMed Web of Science ®Google Scholar
• YaoJCShahMHItoTRAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study GroupEverolimus for advanced pancreatic neuroendocrine tumorsN Engl J Med2011364651452321306238
   PubMed Web of Science ®Google Scholar
• TajimaKNakamuraAShirakawaJMetformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 miceAm J Physiol Endocrinol Metab20133058E987E99823964070
   PubMed Web of Science ®Google Scholar
• ChenHPShiehJJChangCCMetformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studiesGut201362460661522773548
   PubMed Web of Science ®Google Scholar
• SaitoTChibaTYukiKMetformin, a diabetes drug, eliminates tumor-initiating hepatocellular carcinoma cellsPLoS One201387e7001023922888
   PubMed Web of Science ®Google Scholar
• CaiXHuXCaiBMetformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivoOncol Rep20133052449245724008375
   PubMed Web of Science ®Google Scholar
• MiyoshiHKatoKIwamaHEffect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivoInt J Oncol Epub12302013
   Web of Science ®Google Scholar